Recently Released Market Study: R&D Trends 2012
Mounting pressure to reduce the cost of R&D and boost productivity has resulted in pharma companies undertaking radical strategies as the search for efficiency continues. With the ongoing patent cliff triggering a wave of patent expiries, pharmaceutical R&D is at a turning point.
View full press release